“If opportunity doesn’t knock, build a door.” – Milton Berle
@rahulkanadia.bsky.social ky.social, @marubin1.bsky.social and I have launched Verintas Therapeutics Inc.
to target the minor spliceosome in cancer.
Thanks to Nextwave X Partners-our 1st investor and believer.
#Verintas #minorspliceosome
17.08.2025 17:32 — 👍 2 🔁 0 💬 0 📌 0
In cancer research, we chase the “untreatable” — but making current treatments more tolerable matters too. Grateful to the SwissLife Jubiläumsstiftung for supporting my work on minor spliceosome-based co-treatments to ease side effects and improve outcomes.
#swisslife #minorspliceosome #RNAbaseddrug
02.06.2025 12:01 — 👍 2 🔁 0 💬 0 📌 0
:)
06.05.2025 09:35 — 👍 1 🔁 0 💬 0 📌 0
We will put forward a 500 million package for 2025-2027 to make Europe a magnet for researchers.
As well as ambitious proposals for R&I in the next EU budget.
We will also offer the best and brightest the right incentives to come to Europe ↓
05.05.2025 10:02 — 👍 665 🔁 195 💬 22 📌 61
Bluesky is the place for science.
13.03.2025 23:01 — 👍 4103 🔁 511 💬 78 📌 31
BSc,MSc ETH PharmSc @ETH | PhD Chem & Molecular Sc @UniJena, @Helmholtz_HIPS, @unibern | Postdoc @HopkinsMedicine | Almost a polyglot.Amateur guitarist. she/her
#OptoGRC2026 May 10-15, 2026 | @okaysteve.bsky.social, @bjmarlin.bsky.social, @tinakim-neuro.bsky.social & gisellavetere.bsky.social
🔗: www.grc.org/optogenetic-approaches-to-understanding-neural-circuits-and-behavior-conference/2026/
Dpt. for BioMedical Research
International Open Access journal publishing on molecular and translational medicine. IF 2024,9.4; Scopus Citescore 2024, 8.4.
We study how micro-environmental and epigenetic mechanisms drive cancer cells into dormancy. We seek to control this biology to prevent and treat metastasis. https://einsteinmed.edu/faculty/16974/julio-aguirre-ghiso
A career network featuring science jobs in academia and industry.
Visit our platform at www.science.hr
Advancing education, research, and innovation in hematology & oncology. #CancerPrevention #CancerAwareness #CancerSurvivors #CancerCare #HealthEquity #GlobalOncology #GlobalHealth #LGBTQ+🏳️🌈💙
Follow Us: https://buff.ly/MWm1IOU
Associate Professor in the Physiology and Neurobiology Department. We study the minor spliceosome in development and disease
Genome editing and protein engineering
Postdoc, Uni Bern
We are the largest biomedical science hub in the south of Europe, by the beach in Barcelona.
Recerca biomèdica amb vistes |
@researchmar.bsky.social @crg.eu @melisupf.bsky.social @embl.org @isglobal.org @ibe-barcelona.bsky.social @fpmaragall.bsky.social
The Friedrich Miescher Institute for Biomedical Research (FMI), affiliated with @unibas.ch and @novartis.bsky.social, conducts research at the forefront of biomedicine and trains the next leaders in the life sciences.
Offizieller Kanal. News rund um die Uni Bern. Motto: Wissen schafft Wert. Universität Bern #unibern
Mastodon: @unibern@mastodon.online
Impressum: http://ow.ly/mXYsG.
Netiquette: https://www.unibe.ch/aktuell/soziale_medien/netiquette/index_ger.html
Switzerland’s largest research institute for natural and engineering sciences. #ResearchAtPSI
The Swiss National Science Foundation funds excellent research at universities and other institutions – from chemistry to medicine to sociology.
We invest in researchers and their ideas 🔬🌱📚 — www.snf.ch/en
Deutsch & Français: @snf-fns.ch
Research Group Leader at FMI, Switzerland | Expert in Gene Expression | Cycling Enthusiast & Rock Climber
Find me on X as @MarcBhler4 or instagram.com/maggi.buehler
Excited about posttranscriptional gene regulation, in particular translation-coupled mRNA decay, and RNA Biology in general.
SABCS is the world's largest gathering of doctors, researchers and scientists sharing state-of-the-art information on experimental biology, etiology, prevention, diagnosis, and therapy for breast cancer and premalignant breast diseases. www.sabcs.org
Director Translational Breast Cancer Research, Associate Director for Clinical Research, Weill Cornell Medicine, Meyer Cancer Center, NYC; Opinions are my own
We are a cancer genetics lab studying functional genomics of blood cancers. We have a special interest in altered RNA processing in cancer.
We accelerate the pace of innovation in biomedical research and drug discovery & development by combining the best of both worlds – academia and industry. Our innovation model:
https://pubmed.ncbi.nlm.nih.gov/39235485/
